Suppr超能文献

母亲使用减肥产品与子女神经管缺陷风险:系统文献回顾。

Maternal Use of Weight Loss Products and the Risk of Neural Tube Defects in Offspring: A Systematic Literature Review.

机构信息

UTHealth School of Public Health, Department of Epidemiology, Human Genetics, and Environmental Sciences, Houston, Texas.

出版信息

Birth Defects Res. 2018 Jan 15;110(1):48-55. doi: 10.1002/bdr2.1116. Epub 2017 Oct 12.

Abstract

BACKGROUND

Several studies have assessed potential associations between use of weight loss products in the periconceptional period and neural tube defects (NTDs). However, the individual studies are inconclusive and there has not been a systematic review of this literature.

METHODS

We conducted a systematic search, using Ovid MEDLINE and PubMed, to identify studies that evaluated the association between products used for weight loss and the risk of NTDs. Because many studies of birth defects only evaluate a composite birth defect outcome, we evaluated studies that defined the outcome as "any major birth defect" or as NTDs. We abstracted data on study design, exposure definition, outcome definition, covariates and effect size estimates from each article that met our inclusion criteria. For studies that evaluated a composite birth defect outcome, we also abstracted the number of NTD cases included in the composite outcome. We used a modified version of the Newcastle-Ottawa Scale to assess the quality of each article.

RESULTS

We screened 865 citations and identified nine articles that met our inclusion criteria. The majority of studies reported positive associations between maternal use of weight loss products and birth defects (overall and NTDs). However, there were few significant associations and there was considerable heterogeneity in the specific exposures assessed across the nine studies.

CONCLUSION

Our systematic review of weight loss products and NTDs indicates that the literature on this topic is sparse. Because several studies reported modest, positive associations between risk and use of weight loss products, additional studies are warranted. Birth Defects Research 110:48-55, 2018. © 2017 Wiley Periodicals, Inc.

摘要

背景

有几项研究评估了在围孕期使用减肥产品与神经管缺陷(NTD)之间的潜在关联。然而,个别研究的结论并不一致,也没有对这方面的文献进行系统评价。

方法

我们使用 Ovid MEDLINE 和 PubMed 进行了系统搜索,以确定评估用于减肥的产品与 NTD 风险之间关联的研究。由于许多出生缺陷的研究仅评估了复合出生缺陷的结果,因此我们评估了将结果定义为“任何重大出生缺陷”或 NTD 的研究。我们从符合纳入标准的每篇文章中提取了研究设计、暴露定义、结果定义、协变量和效应量估计的数据。对于评估复合出生缺陷结果的研究,我们还从复合结果中提取了 NTD 病例的数量。我们使用了纽卡斯尔-渥太华量表的修改版来评估每篇文章的质量。

结果

我们筛选了 865 条引文,确定了 9 篇符合纳入标准的文章。大多数研究报告了母亲使用减肥产品与出生缺陷(整体和 NTD)之间存在正相关。然而,仅有少数显著关联,而且在这 9 项研究中评估的具体暴露存在很大的异质性。

结论

我们对减肥产品与 NTD 进行的系统评价表明,关于这个主题的文献很少。由于几项研究报告了风险与使用减肥产品之间存在适度的正相关,因此需要进一步的研究。出生缺陷研究 110:48-55, 2018. © 2017 Wiley Periodicals, Inc.

相似文献

3
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
6
9
Antioxidants for male subfertility.抗氧化剂治疗男性不育。
Cochrane Database Syst Rev. 2022 May 4;5(5):CD007411. doi: 10.1002/14651858.CD007411.pub5.
10
Methods for blood loss estimation after vaginal birth.阴道分娩后失血估计方法。
Cochrane Database Syst Rev. 2018 Sep 13;9(9):CD010980. doi: 10.1002/14651858.CD010980.pub2.

本文引用的文献

3
Weight management in obesity - past and present.肥胖症的体重管理——过去与现在
Int J Clin Pract. 2016 Mar;70(3):206-17. doi: 10.1111/ijcp.12771. Epub 2016 Jan 26.
5
Antiobesity drugs in early pregnancy and congenital malformations in the offspring.孕早期使用抗肥胖药物与子代先天性畸形
Obes Res Clin Pract. 2014 Nov-Dec;8(6):e571-6. doi: 10.1016/j.orcp.2013.11.008. Epub 2013 Dec 17.
6
Meta- and cost-effectiveness analysis of commercial weight loss strategies.商业减肥策略的荟萃分析和成本效益分析。
Obesity (Silver Spring). 2014 Sep;22(9):1942-51. doi: 10.1002/oby.20824. Epub 2014 Jun 24.
8
Appetite suppressants in pregnancy.孕期食欲抑制剂
Neuro Endocrinol Lett. 2012;33 Suppl 3:179-82.
10
Can benfluorex induce congenital malformations?苯氟雷司会导致先天性畸形吗?
Diabetes Metab. 2012 Oct;38(4):373-4. doi: 10.1016/j.diabet.2012.02.013. Epub 2012 May 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验